Description
EGFR inhibitor Erlotinib treatment can induce NHBE into profound cell cycle arrest that include senescence and quiescence. Because senescent cells feature high senescence assocaited-beta-galactosidase(SA--gal) activty, which has been used as marker for FACS based collection of senescent and quiescent cells, respectively.